2021
DOI: 10.3389/fonc.2021.645821
|View full text |Cite
|
Sign up to set email alerts
|

Monoamine Oxidase A Inhibits Lung Adenocarcinoma Cell Proliferation by Abrogating Aerobic Glycolysis

Abstract: Lung adenocarcinoma (LUAD) accounts for ~30% of all lung cancers and is one of the causes of cancer-related death worldwide. As the role of monoamine oxidase A (MAOA) in LUAD remains unclear, in this study, we examine how MAOA affects LUAD cell proliferation. Analyses of both public data and our data reveal that the expression of MAOA is downregulated in LUAD compared with non-tumor tissue. In addition, the expression of MAOA in tumors correlates with clinicopathologic features, and the expression of MAOA serv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 41 publications
0
4
0
Order By: Relevance
“…This approach identified more than half the genes (17/27) in these BRCA samples that have recently been recognised for their tumour-suppressive capacities in a range of sporadic cancers, with others apparently underexplored ( Table S1 , Tab#2). Several prime examples are functionally linked to metabolism: monoamine oxidase A (MAOA) inhibits aerobic glycolysis and immunity in lung cancer [ 49 ]; Integral Membrane Protein 2A (ITM2A) in BRCA induces PD-1 and higher tumour infiltrating lymphocyte (TIL) infiltration [ 50 ]; and GRB2-associated binding protein 3 (GAB3) drives natural killer cell priming and expansion [ 51 ].…”
Section: Resultsmentioning
confidence: 99%
“…This approach identified more than half the genes (17/27) in these BRCA samples that have recently been recognised for their tumour-suppressive capacities in a range of sporadic cancers, with others apparently underexplored ( Table S1 , Tab#2). Several prime examples are functionally linked to metabolism: monoamine oxidase A (MAOA) inhibits aerobic glycolysis and immunity in lung cancer [ 49 ]; Integral Membrane Protein 2A (ITM2A) in BRCA induces PD-1 and higher tumour infiltrating lymphocyte (TIL) infiltration [ 50 ]; and GRB2-associated binding protein 3 (GAB3) drives natural killer cell priming and expansion [ 51 ].…”
Section: Resultsmentioning
confidence: 99%
“…Similar results can be observed in lung cancer. Monoamine oxidase A has a positive to poor prognosis and can promote aerobic glycolysis through HK2 [ 155 ]. In prostate cancer, increased monoamine oxidase A induces ROS-mediated apoptosis under androgen deprivation [ 156 ].…”
Section: Possible Connections Between Let-7 -Mediated Glycolysis and Autophagy In Cancer Progressionmentioning
confidence: 99%
“…[18] Additionally, MAOA which catalyzes the oxidative deamination of dopamine, serotonin, and the other amines is overexpressed in NSCLC, [19] while another study suggested that MAOA is downregulated in LUAD. [20] Thus, we speculate that the NRCRGs model might exist prognostic value for patients with LUAD. In this study, we integrated the genomic information of LUAD patients from multiple datasets to develop and validate a 3 NRCRGs prognostic model named “Neurotransmitter release cycle (NRC) score.” Furthermore, the NRC score constructed based on the prognostic model was associated with immunotherapy-related anti-cancer immunity and inflamed TME characteristics.…”
Section: Introductionmentioning
confidence: 98%